First-in-class CCR8 antagonist IPG-051 displays good preclinical antitumor activity
June 13, 2023
Chemokine (C-C motif) receptor 8 (CCR8), a member of the β chemokine receptor family, contributes to the recruitment and immunosuppressive function of regulatory T (Treg) cells within the tumor microenvironment.